Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neuphoria Therapeutics Inc

13.03
+0.04000.31%
Volume:10.77K
Turnover:139.97K
Market Cap:29.47M
PE:7.67K
High:13.20
Open:12.99
Low:12.63
Close:12.99
52wk High:13.34
52wk Low:2.90
Shares:2.26M
Float Shares:1.23M
Volume Ratio:0.37
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0017
EPS(LYR):-0.0086
ROE:25.45%
ROA:-1.01%
PB:1.13
PE(LYR):-1,511.95

Loading ...

Company Profile

Company Name:
Neuphoria Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
- -
Office Location:
100 Summit Dr,Burlington,Massachusetts,United States
Zip Code:
01803
Fax:
- -
Introduction:
- -

Directors

Name
Position
Spyros Papapetropoulos
President, Chief Executive Officer and Director
Alan Fisher
Chair of the Board
Aaron Weaver
Director
David Wilson
Director
Jane Ryan
Director
Miles Davies
Director

Shareholders

Name
Position
Spyros Papapetropoulos
President, Chief Executive Officer and Director
Tim Cunningham
Chief Financial Officer